Vinicius Nahime Brito Selected Research

Precocious Puberty

1/2021	Insights from the genetic characterization of central precocious puberty associated with multiple anomalies.
1/2020	Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.
8/2019	Pioneering studies on monogenic central precocious puberty.
5/2017	Assessment of stress levels in girls with central precocious puberty before and during long-acting gonadotropin-releasing hormone agonist treatment: a pilot study.
1/2016	Sexual Precocity--Genetic Bases of Central Precocious Puberty and Autonomous Gonadal Activation.
3/2014	[Advances in the etiology, diagnosis and treatment of central precocious puberty].
1/2013	Molecular and gene network analysis of thyroid transcription factor 1 (TTF1) and enhanced at puberty (EAP1) genes in patients with GnRH-dependent pubertal disorders.
1/2013	The benign spectrum of hypothalamic hamartomas: infrequent epilepsy and normal cognition in patients presenting with central precocious puberty.
7/2008	Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
7/2008	Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinicius Nahime Brito Research Topics

Disease

15	Precocious Puberty 01/2021 - 04/2006
3	Obesity 01/2020 - 04/2013
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020 - 04/2013
2	Virilism (Virilization) 01/2019 - 04/2006
2	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 01/2016 - 02/2008
2	Familial Testotoxicosis 07/2008 - 04/2006
1	Overweight 01/2020
1	Neoplasms (Cancer) 01/2019
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2019
1	Diaper Rash 01/2019
1	Atherosclerosis 04/2013
1	Hypertension (High Blood Pressure) 04/2013
1	Hypothalamic hamartomas 01/2013
1	Epilepsy (Aura) 01/2013
1	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2007
1	Amenorrhea 02/2005

Drug/Important Bio-Agent (IBA)

6	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021 - 01/2013
6	GonadotropinsIBA 03/2014 - 06/2006
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020 - 07/2008
3	LH Receptors (LH Receptor)IBA 07/2008 - 04/2006
2	AndrogensIBA 01/2019 - 04/2006
2	Testosterone (Sustanon)FDA Link 01/2019 - 04/2006
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016
1	Kisspeptin-1 ReceptorsIBA 01/2016
1	Contraceptive Agents (Contraceptives)IBA 01/2015
1	Hormones (Hormone)IBA 01/2015
1	LipidsIBA 04/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	polyalanineIBA 01/2013
1	Cyproterone AcetateIBA 07/2008
1	Ketoconazole (Nizoral)FDA LinkGeneric 07/2008
1	4-(fluoromethyl)phenyl phosphate (FMPP)IBA 07/2008
1	Biological ProductsIBA 02/2008
1	Proline (L-Proline)FDA Link 02/2008
1	Codon (Codons)IBA 02/2008
1	Arginine (L-Arginine)FDA Link 02/2008
1	Staphylococcal Protein A (Protein A)IBA 02/2008
1	SteroidsIBA 02/2008
1	NeuropeptidesIBA 03/2007
1	gamma-Aminobutyric Acid (GABA)IBA 06/2006
1	GABA-A Receptors (GABA(A) Receptor)IBA 06/2006
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 04/2006
1	DNA (Deoxyribonucleic Acid)IBA 04/2006
1	isolated Follicle-stimulating hormone deficiencyIBA 02/2005

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2020